GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hansoh Pharmaceutical Group Co Ltd (HKSE:03692) » Definitions » Beneish M-Score

Hansoh Pharmaceutical Group Co (HKSE:03692) Beneish M-Score : -2.48 (As of May. 04, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Hansoh Pharmaceutical Group Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.48 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Hansoh Pharmaceutical Group Co's Beneish M-Score or its related term are showing as below:

HKSE:03692' s Beneish M-Score Range Over the Past 10 Years
Min: -3.04   Med: -2.43   Max: 1.02
Current: -2.48

During the past 8 years, the highest Beneish M-Score of Hansoh Pharmaceutical Group Co was 1.02. The lowest was -3.04. And the median was -2.43.


Hansoh Pharmaceutical Group Co Beneish M-Score Historical Data

The historical data trend for Hansoh Pharmaceutical Group Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansoh Pharmaceutical Group Co Beneish M-Score Chart

Hansoh Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial -3.04 1.02 0.33 -2.38 -2.48

Hansoh Pharmaceutical Group Co Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 - -2.38 - -2.48

Competitive Comparison of Hansoh Pharmaceutical Group Co's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Hansoh Pharmaceutical Group Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hansoh Pharmaceutical Group Co's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hansoh Pharmaceutical Group Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Hansoh Pharmaceutical Group Co's Beneish M-Score falls into.



Hansoh Pharmaceutical Group Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Hansoh Pharmaceutical Group Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8297+0.528 * 1.0107+0.404 * 1.1394+0.892 * 1.0548+0.115 * 0.8993
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9495+4.679 * 0.004874-0.327 * 0.9062
=-2.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was HK$3,531 Mil.
Revenue was HK$11,051 Mil.
Gross Profit was HK$9,924 Mil.
Total Current Assets was HK$31,592 Mil.
Total Assets was HK$36,137 Mil.
Property, Plant and Equipment(Net PPE) was HK$3,603 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$401 Mil.
Selling, General, & Admin. Expense(SGA) was HK$4,639 Mil.
Total Current Liabilities was HK$7,506 Mil.
Long-Term Debt & Capital Lease Obligation was HK$114 Mil.
Net Income was HK$3,585 Mil.
Gross Profit was HK$0 Mil.
Cash Flow from Operations was HK$3,409 Mil.
Total Receivables was HK$4,035 Mil.
Revenue was HK$10,477 Mil.
Gross Profit was HK$9,509 Mil.
Total Current Assets was HK$28,847 Mil.
Total Assets was HK$33,504 Mil.
Property, Plant and Equipment(Net PPE) was HK$3,890 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$385 Mil.
Selling, General, & Admin. Expense(SGA) was HK$4,632 Mil.
Total Current Liabilities was HK$2,925 Mil.
Long-Term Debt & Capital Lease Obligation was HK$4,871 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(3530.595 / 11051.33) / (4034.505 / 10477.475)
=0.319472 / 0.385065
=0.8297

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(9509.273 / 10477.475) / (9923.793 / 11051.33)
=0.907592 / 0.897973
=1.0107

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (31591.951 + 3602.525) / 36137.447) / (1 - (28846.55 + 3889.726) / 33503.54)
=0.026094 / 0.022901
=1.1394

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=11051.33 / 10477.475
=1.0548

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(384.822 / (384.822 + 3889.726)) / (400.74 / (400.74 + 3602.525))
=0.090026 / 0.100103
=0.8993

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(4638.724 / 11051.33) / (4631.786 / 10477.475)
=0.419744 / 0.442071
=0.9495

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((114.245 + 7506.439) / 36137.447) / ((4871.459 + 2925.236) / 33503.54)
=0.210881 / 0.232713
=0.9062

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(3584.864 - 0 - 3408.727) / 36137.447
=0.004874

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Hansoh Pharmaceutical Group Co has a M-score of -2.48 suggests that the company is unlikely to be a manipulator.


Hansoh Pharmaceutical Group Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Hansoh Pharmaceutical Group Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Hansoh Pharmaceutical Group Co (HKSE:03692) Business Description

Traded in Other Exchanges
Address
287 Xiangke Road, Pudong New District, Shanghai, CHN, 201210
Hansoh Pharmaceutical Group Co Ltd is a research and development-driven pharmaceutical company in China. The company holds a broad, diversified drug portfolio in CNS diseases, oncology, anti-infectives, and diabetes. Further, it also focuses on metabolic diseases and anti-tumor. The majority of revenue is generated from the sale of pharmaceutical products in Mainland China.

Hansoh Pharmaceutical Group Co (HKSE:03692) Headlines

No Headlines